| Ben Edgar Cottrell, MD | |
|
705 Black Creek Dr, Chattanooga, TN 37419-2190 | |
| (931) 588-6356 | |
| Not Available |
| Full Name | Ben Edgar Cottrell |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 27 Years |
| Location | 705 Black Creek Dr, Chattanooga, Tennessee |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801842570 | NPI | - | NPPES |
| 3862460 | Medicaid | TN | |
| TN0109 | Other | TN | AMERICHOICE |
| 3862466 | Medicaid | TN | |
| 4144771 | Other | TN | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 35175 (Tennessee) | Secondary |
| 207P00000X | Emergency Medicine | 35175 (Tennessee) | Primary |
| 207Q00000X | Family Medicine | 35175 (Tennessee) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Parkridge Medical Center | Chattanooga, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Emergency Medicine Services Of Tn, Pc | 3173989837 | 49 |
| Fort Oglethorpe Emergency Physicians Group Llc | 8527323633 | 8 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Coffee Medical Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013969179 PECOS PAC ID: 1850208794 Enrollment ID: O20031118000203 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Emergency Staffing Solutions Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477590974 PECOS PAC ID: 9830001650 Enrollment ID: O20120127000382 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Spring Creek Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1275961799 PECOS PAC ID: 8729218110 Enrollment ID: O20140304001787 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Tennessee River Physicians, Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396282463 PECOS PAC ID: 8022387349 Enrollment ID: O20170629002555 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Hospital Medicine Services Of Tn Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982301065 PECOS PAC ID: 2365807633 Enrollment ID: O20230421000177 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Emergency Medicine Services Of Tn, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720785884 PECOS PAC ID: 3173989837 Enrollment ID: O20230523000265 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Entity Name | Sycamore Physicians Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780372557 PECOS PAC ID: 9032573902 Enrollment ID: O20240227002736 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ben Edgar Cottrell, MD 705 Black Creek Dr, Chattanooga, TN 37419-2190 Ph: (931) 588-6356 | Ben Edgar Cottrell, MD 705 Black Creek Dr, Chattanooga, TN 37419-2190 Ph: (931) 588-6356 |
News Archive
In a study to be presented on Feb. 6 in an oral concurrent session at 1:15 p.m. PST, at the Society for Maternal-Fetal Medicine's annual meeting, The Pregnancy Meeting™, in San Diego, researchers will present findings on a study of mothers and daughters where low birth weight and preeclampsia were found to reoccur in the next generation.
AVANIR Pharmaceuticals, Inc., today announced it will present three scientific posters featuring detailed Zenvia™ (dextromethorphan/quinidine) safety and efficacy data from the double-blind phase and the open label extension of the Phase III confirmatory STAR trial at the American Academy of Neurology Annual Meeting in Toronto, Canada, taking place April 10 - 17, 2010.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
The U.S. Food and Drug Administration (FDA) has issued the results of its interim safety and risk assessment of melamine and melamine-related compounds in food, including infant formula.
While next month's election will likely affect how states implement the health law's insurance exchange and Medicaid expansion provisions, state legislators are facing - and making - decisions on them now.
› Verified 1 days ago
Joseph Kerby Gray, MD Emergency Medicine Medicare: May Accept Medicare Assignments Practice Location: 2525 De Sales Ave, Chattanooga, TN 37404 Phone: 423-495-2525 | |
Ronald A. Gracy Ii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 941 Spring Creek Rd, Chattanooga, TN 37412 Phone: 423-894-7870 Fax: 865-539-8008 | |
Dr. Jocelyn May De Guzman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1755 Gunbarrel Rd, Chattanooga, TN 37421 Phone: 423-680-8534 | |
Dr. Jeffrey Durant Clinkscales, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7628 | |
Dr. Shelley L Murphy, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1018 Blackford Street, Chattanooga, TN 37403 Phone: 423-778-7000 | |
Samuel Wilson, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2525 Desales Ave, Chattanooga, TN 37404 Phone: 423-697-0014 Fax: 423-648-6280 | |
Dr. James B Bardoner, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 975 E 3rd St, Chattanooga, TN 37403 Phone: 423-778-7296 Fax: 423-778-8086 |